Cargando…
Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: a meta-epidemiological investigation
BACKGROUND: The low data publication rate for Food and Drug Administration (FDA)-approved drugs, and discrepancies between FDA-submitted versus published data, remain a concern. We investigated the publication statuses of sponsor-submitted clinical trials supporting recent anticancer drugs approved...
Autores principales: | Omae, Kenji, Kataoka, Yuki, Tsujimoto, Yasushi, Tsutsumi, Yusuke, Yamamoto, Yosuke, Fukuhara, Shunichi, Furukawa, Toshi A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814120/ https://www.ncbi.nlm.nih.gov/pubmed/31651263 http://dx.doi.org/10.1186/s12885-019-6232-x |
Ejemplares similares
-
Association between statistical significance and time to publication among systematic reviews: a study protocol for a meta-epidemiological investigation
por: Tsujimoto, Yasushi, et al.
Publicado: (2017) -
Proportion attributable to contextual effects in general medicine: a meta-epidemiological study based on Cochrane reviews
por: Tsutsumi, Yusuke, et al.
Publicado: (2023) -
Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysis
por: Omae, Kenji, et al.
Publicado: (2017) -
Background styles in systematic review articles are not related to the publication in high-impact-factor journals: A meta-epidemiological study
por: Kataoka, Yuki, et al.
Publicado: (2020) -
US Food and Drug Administration Accelerated Approval Program for Nononcology Drug Indications Between 1992 and 2018
por: Omae, Kenji, et al.
Publicado: (2022)